A carregar...
Comparison of the potassium channel blocker tedisamil with the beta‐adrenoceptor blocker esmolol and the calcium antagonist gallopamil in patients with coronary artery disease
Background: Tedisamil is a new bradycardic agent proven to exert anti‐ischemic and antiarrhythmic effects by blockade of the different cardiac and vascular K(+) currents. Hypothesis: It was the aim of the present study to compare the favorable anti‐ischemic effects of tedisamil, with two long establ...
Na minha lista:
| Publicado no: | Clin Cardiol |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Wiley Periodicals, Inc.
2009
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6655832/ https://ncbi.nlm.nih.gov/pubmed/9669058 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.4960210708 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|